Trial intelligence / Profile preview

Adoport PK in de novo kidney transplantation (IMPAKT)

NCT03076151Phase 4Completed

Sponsor
CHU de Limoges
Start
Feb 2018
Primary completion
Jul 2019
Modality
Small Molecules
Countries
1
01

Overview

A Phase 4 trial of tacrolimus in kidney transplantation, sponsored by CHU de Limoges. Started Feb 2018; status: completed.

02

Drugs

tacrolimus
03

Conditions

kidney transplantation

Beyond the preview

Go deeper on NCT03076151.

Study design, results and competitive context are available in the Gosset platform where reported.

Study design & results

Available in the Gosset platform where reported.

Competitive context

Available in the Gosset platform where reported.

Bring the full picture into focus.

See how Gosset can support your research on NCT03076151.

Gosset Free

Get started with Gosset.

Enter your corporate email.

Work email preferred.

Book a call